drugset / Trial / NCT00131924

High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy

NCT00131924 ↗

Open-labelTreatment

Summary

RATIONALE: High doses of esterified estrogens may stop the growth of breast cancer cells that no longer respond to hormone therapy. PURPOSE: This phase II trial is studying how well high-dose esterified estrogens work in treating postmenopausal women with metastatic breast cancer that has failed previous hormone therapy.

Timeline

Start
2004-03
Primary completion
2006-01
Completion
2006-01

Outcome

Outcome not reported

Stopped (Enrollment): “Data Monitoring Committee recommended closure due to poor accrual.”

Drugs

EvaluationDrugModalityDoseRoute
Subject ESTROGENS, ESTERIFIED Unknown — Oral

Indications